Eczematous Disorders CFM REPORT 2.ppt

Embed Size (px)

Citation preview

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    1/32

    ECZEMATOUSDISORDERS

    JI Cortez, Arianne M.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    2/32

    A general term for pruritic rash

    is a skin disease that is characterized by: erythematous vesicular, weeping, and crusting

    patches.

    Itching is a characteristic symptom Epidermal intercellular edema (spongiosis) is a

    characteristic histopathologic finding ofeczematous conditions.

    The term eczema is also commonly used to referto atopic dermatitis

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    3/32

    ATOPIC DERMATITIS

    common chronic inflammatory dermatosis thatgenerally begins in infancy.

    The term atopy was coined in the early 1920s todescribe the associated triad of asthma, allergicrhinitis, and dermatitis follows theremitting/recurrent course that may continuethrough life

    In 80% of patients with AD, however, serumimmunoglobulin IgE is elevated, sometimesmarkedly.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    4/32

    Infantile Childhood Adolescent/

    AdultAge of

    onset

    2mos 2 years 2-6 years old > 6 years old

    Areas

    Affected

    cheeks

    forehead

    extensorsforearm

    antecubital and

    popiteal areas

    wristseyelids

    face

    neck

    whole body

    flexural

    Types of Atopic dermatitis:

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    5/32

    ACUTE LESIONS OF AD

    eczematouserythematous, scaling, andpapulovesicular. Weeping and crusted lesions maydevelop. Scratching results acutely in linear excoriations,presenting as erosions or a hemorrhagic crust.

    In extremely severe cases, exfoliative dermatitis(erythroderma) may occur, with generalized redness,scaling, weeping, and crusting.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    6/32

    Treatment: Anti-histamines (H1 Blockers)

    Corticosteroids

    Tar bath preparation

    UVL for severe pruritus Therapeutic baths, compress and cleansers

    Moisturizers

    Cyclosporine if generalized and severe

    Interferon gamma

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    7/32

    CHRONI LESIONS OF AD

    Tend NOT to be eczematous Instead, lichenified plaques or

    nodules predominate. Lichenification

    denotes areas of thickened skin divided

    by deep linear furrows. Lichenified plaques result from

    repeated rubbing or scratching and

    thus often occur in areas of

    predilection, such as the popliteal

    and antecubital fossae.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    8/32

    CONTACT DERMATITIS

    can be either allergic or irritant in etiology.

    Clinical Presentation:

    Pruritic, erythematous, edematous papules,

    and plaques Sharp margins

    Geometric or linear configuration

    Conforms to area of contact

    Vesicles and bullae common

    Linear lesions or pattern of contact

    Toxicodendron species (poison ivy,

    oak, sumac) common culprits

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    9/32

    Patch testing may be required to confirm the diagnosis.

    The manifestations of irritant contact dermatitis aresimilar to those of allergic contact dermatitis in the irritant

    form, however, the mechanism is not immunologic.

    Given sufficient concentration and duration of contact,offending agents will induce irritation in anyones skin.Detergents, acids, alkalis, solvents, formaldehyde, and

    fiberglass are common causes

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    10/32

    Treatment: Identify and remove irritants and

    allergens

    Lukewarm baths Apply lubricant immediately following

    the bath

    Learn to recognize skin infections and

    seek treatment promptly

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    11/32

    SEBORRHEIC DERMATITIS

    Clinically, may exist without vesicleformation.

    Lesional morphology is usually agreasy scale on erythematous

    patches; however, the scale may bedry, and the patches may have anorange hue.

    Typical Areas of Involvement: Scalp, eyebrows, mustache area,

    nasolabial folds, and chest Psoriasis may be part of the

    differential diagnosis.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    12/32

    Treatment: Selenium Sulfide (Selsun Blue)

    Ketoconazole (Nizoral)

    Zinc Pyrithionate (Guard, Head & Shoulders)

    Resorcin

    Tar

    Corticosteroid creams

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    13/32

    DIAPER DERMATITIS

    An erythematous and papulovesical dermatitisdistributed over the lower abdomen, genitals,thigh and the convex surfaces of the buttocks

    Complications:

    a. punched-out ulcers or erosions with elevated

    borders (Jacquets erosive diaper dermatitis)b. pseudoverrucous papules and nodules

    c. 0.5 to 4 cm violaceous plaques and nodules

    (granuloma gluteal infantum)

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    14/32

    Treatment: Prevention is the best treatment

    Zinc oxide paste or other ointments such as 1-2-

    3 ointment are excellent:

    Burrows solution -1part

    Anhydrous lanolin -2 parts

    Lassars paste w/o -3 parts

    salicylic acid Equal parts Nystatin ointment and 1%

    hydrocortisone ointment

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    15/32

    NUMMULAR DERMATITIS

    well-demarcated, coin-shapedeczematous patches that are usually

    2 to 4 cm (rarely more than 10 cm) in

    diameter. May be vesicular, but more often with

    scale and crust.

    Lower extremities commonlyinvolved in men

    The lesions are quite pruritic.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    16/32

    Treatment:

    Requires potent topical steroids,

    antihistamines, and, occasionally,

    intralesional or systemic corticosteroids for

    treatment.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    17/32

    DYSHIDROTIC DERMATITIS

    Pruritic deep-seated vesicles involvinglateral aspects of digits, palms, and soles,maybe accompanied by hyperhidrosis.

    Typically, 1 to 2 mm vesicles appear onthe sides of fingers, although moreextensive involvement can occur.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    18/32

    Treatment:

    with compresses and soaks, antipruritics,

    topical steroids, and, in severe recalcitrant

    cases, systemic corticosteroids.

    Photochemotherapy with topical psoralen

    and ultraviolet A irradiation (PUVA) may

    also be effective.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    19/32

    OTHERS

    Stasis Dermatitis: pruritic erythematous and hyperpigmented

    papules and lichenified plaques in lower legs

    Eczematous drug eruption

    Nonspecific dermatitis that is usuallywidespread and pruritic

    Autoeczematezation reaction

    Poorly defined papular eruptionthat follows an acute dermatitis

    of the hands or feet

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    20/32

    DIAGNOSIS

    The list of medical tests mentioned in various sources asused in the diagnosis of Eczema includes:

    Physical exam

    Skin scratch/prick tests need careful interpretation.

    Blood tests for airborne allergens often not very usefulfor diagnosis.

    Eosinophil levelsIgE levels

    Food diary to watch for food allergies

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    21/32

    Patch Test

    - used to detect hypersensitivity to a substance that is in

    contact with the skin so that the allergen may be

    determined and corrective measures taken

    - confirmatory and diagnostic

    - application to the intact uninflammed skin, in non-irritating concentration, of substances suspected to becauses of the contact dermatitis

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    22/32

    MAJOR CRITERIA

    Personal or family history of atopy (atopic dermatitis,allergic rhinitis, allergic conjunctivitis, allergic blepharitis,

    or asthma)

    Characteristic morphology and distribution of lesions

    Chronic or chronically recurring dermatosis

    Pruritus

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    23/32

    MINOR CRITERIA Hyperimmunoglobulinemia E

    Food intolerance Intolerance to wool and lipid solvents

    Recurrent skin infections

    Xerosis

    Sweat-induced pruritus

    White dermatographism

    Ichthyosis

    Chronically scaling scalp

    Accentuation of hair follicles

    Recurrent conjunctivitis

    Anterior subcapsular cataracts and keratoconus

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    24/32

    HOME REMEDIES

    Changing your laundry detergent

    Prevent dry skin by taking warm (not hot) showers ratherthan baths. Use a mild soap or body cleanser. Dryyourself very carefully and apply moisturizing skin lotions

    all over your body. Avoid lotions with fragrances or otherirritating substances.

    Avoid wearing tight-fitting, rough, or scratchy clothing.

    Avoid scratching the rash.

    Anything that causes sweating can irritate the rash.Avoid strenuous exercise during a flare.

    Cold compress

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    25/32

    NUT SCRUB

    Walnuts contain essential fatty acids that help to soften the skin.

    They are widely used to treat skin conditions such as fungalinfections, warts, eczema and psoriasis.

    OATMEAL SCRUB

    Oats contain beta-glucan, which is often found in the cellulose ofplants. It creates a film on the surface of the skin, allowing the skinto retain its moisture, which makes it very valuable in the treatmentof eczema.

    ALOE VERA

    anti-fungal, healing, cooling and anti-inflammatory properties.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    26/32

    Coconut oilapplied to portions with

    eczema, helps the the skin to remain soft.

    1 tbsp of turmeric powder and bitter neem

    leaves

    Papaya seeds mashed and applied on

    areas to prevent itching of the skin with

    eczema

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    27/32

    TREATMENT

    Reduction of Trigger Factors

    Reduction of trigger factors (harsh chemicals,

    detergents, and wool) and avoidance of

    occupations that require contact with triggerfactors (hairdressing, and construction) can

    be helpful.

    Appropriate behaviors should be taught topatients and parents early during life, when

    habits are more easily formed.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    28/32

    Bland Emollients

    The use of mild, nonalkali soaps and frequent use of

    emollients are important elements in the long-term

    management of AD.

    Corticosteroids

    Application immediately after bathing improves

    cutaneous penetration.

    Long-term use of inadequately potent topical

    corticosteroids may pose a greater risk of adverse

    effects than brief use of more potent agents followed

    by a rapid taper to bland emollients.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    29/32

    Antihistamines

    can sometimes be helpful in breaking the itch-scratch cycle in AD. Sedating antihistamines,such as hydroxyzine and diphenhydramine,

    are particularly usefulespecially whenitching prevents sleep

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    30/32

    Antidepressants

    Doxepin, a tricyclic antidepressant known to

    have antihistaminic effects, can be beneficialwhen applied topically in a 5% cream.

    Phototherapy

    Virtually every phototherapy regimen hasbeen reported to ameliorate AD.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    31/32

    Antimicrobials

    are obviously important for patients with

    infection. Less clear is whether antimicrobial

    agents can directly treat AD by reducingbacterial products thought to exacerbate the

    condition.

  • 7/31/2019 Eczematous Disorders CFM REPORT 2.ppt

    32/32

    THANK YOU

    Arianne M. Cortez